Online Consultation with Oncologist Doctors Abroad — Page 6

The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.

The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

Dr. Shruti Kate is a medical oncologist at HCG Manavata Cancer Centre in Nashik. She previously worked as a consultant at the Tata Memorial Hospital in Mumbai. Dr. Kate focuses on immunotherapy and metronomic therapy for treating solid and pediatric tumors. She was the sole recipient from India of the 2018 World Conference on Lung Cancer award.

• Specializes in the treatment of lung, breast, gynecological, and genitourinary cancers.
• Proficient in complex procedures, including the Whipple surgery and chemotherapy management.
• Member of ASCO, ESMO, and the International Association for the Study of Lung Cancer.
• Practices at the NABH-accredited HCG Manavata Cancer Centre.

The doctor has conducted significant research on the cumulative effective dose of radiation from chest CT scans in COVID-19 patients. This work highlights the importance of adhering to guidelines to minimize unnecessary exposure, reflecting a commitment to patient safety and evidence-based practice.

Prof. Dr. Suna Emir graduated from Hacettepe University Faculty of Medicine in 1989. She completed her pediatrics residency at Hacettepe University from 1990 to 1995. In 2001, she finished her pediatric oncology subspecialty at the Hacettepe University Oncology Institute. She became an Associate Professor in 2004. From 2004 to 2009, she worked at Ankara Dışkapı Children's Health and Diseases Training and Research Hospital and founded the Pediatric Oncology Clinic there. In 2009, she served as Deputy Chief of Pediatric Oncology. From 2009 to 2016, she was a pediatric hematology–oncology training officer at the Ankara Children's Health and Diseases Hematology–Oncology Training and Research Hospital. Since 2019, she has been a Professor and founding faculty member in Child Health and Diseases at Atilim University.

She is an expert in general pediatrics and pediatric hematology–oncology. She is active in residency and subspecialty training. Her clinical interests include childhood diseases from birth to 18 years, lymphoma, solid tumors, autologous bone marrow transplantation, anemia, bleeding disorders, hereditary blood diseases, hemangiomas and other benign tumors, and enlarged lymph nodes.

Dr. Kadri Yamac is an internist and hematologist. He earned his medical degree from Ankara University Faculty of Medicine (1976–1982). He completed Internal Medicine training at Gazi University Faculty of Medicine (1984–1989). He then completed a Hematology subspecialty at Gazi University Faculty of Medicine (1990–1993). He became an Associate Professor at Gazi University Faculty of Medicine in 1995. He was promoted to Professor in 2002.

Medical interests: anemias, coagulation disorders, hemochromatosis, chronic lymphocytic leukemia, lymph node diseases, non-Hodgkin lymphoma, Hodgkin lymphoma.

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.

• Expert in functional rehabilitation for patients recovering from oral cancer.
• Active researcher with multiple publications in various medical journals.
• Works at an NABH-accredited center that treats over 75,000 patients yearly.
• Treats complex conditions including tongue, thyroid, and tonsil cancers.

Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.

• Specializes in minimally invasive procedures, including laparoscopy and thoracoscopy.
• Performs robotic cancer surgeries and advanced endoscopic procedures.
• Served as a former assistant professor at the State Cancer Institute.
• Acts as a co-principal investigator for original clinical research projects.
• Treats complex esophageal, stomach, colon, and rectal cancers.

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in the molecular basis of cancer and targeted therapies. Dr. Valame completed his DNB training in medical oncology at Indraprastha Apollo Hospital. He previously served as a registrar at Jawaharlal Nehru Cancer Hospital.

• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco.
• Expert in chemotherapy and targeted therapy for breast, lung, and gastrointestinal cancers.
• Treats various solid tumors, pediatric cancers, and hematological malignancies.
• Works at an NABH-accredited center that treats over 75,000 patients annually.

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.

• Participated as a lead investigator in more than 200 clinical trials.
• Serves as a professor for DNB Superspecialty Surgical Oncology.
• Expert in complex procedures including mastectomy and thoracic resections.
• Founder of Curie Manavata Cancer Centre, a major regional treatment hub.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.